Literature DB >> 10222132

Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin.

R Dardik1, J Lahav.   

Abstract

Thrombospondin-1 (TSP-1) interacts specifically with heparin and fibronectin in vitro and colocalizes with fibronectin and heparan sulfate in the extracellular matrix (ECM). Its conformation is strongly dependent on Ca2+ concentration. We have previously shown that both heparin and fibronectin have two binding sites on the TSP-1 subunit which may require conformational change for their occupancy (R. Dardik and J. Lahav, 1987, Eur. J. Biochem. 168, 347; ibid 1989, 185, 581). To investigate the effect of TSP-1 binding to fibronectin and heparin on its functional conformation, TSP-1 was subjected to proteolysis in the presence and absence of ligands and of Ca2+. We found that while trypsin cleavage of free TSP-1 resulted in the inactivation of ligand binding, TSP-1 bound to either fibronectin or heparin remained stably associated with these ligands. Cleavage by thrombin or tissue plasminogen activator (tPA) showed that Ca2+-depleted TSP-1, when bound to fibronectin or to heparin, yielded proteolytic cleavage patterns typical of the Ca2+-containing form. Cleavage by chymotrypsin was not affected by binding to fibronectin or heparin; hence loss of proteolytic susceptibility was not due to steric hindrance by the ligands. Taken together, these results indicate that: (A) binding of TSP-1 to fibronectin or heparin is a two-step mechanism where binding to one site leads to conformational changes that enable binding to the second site; (B) TSP-1 in complex with fibronectin or heparin adopts the Ca2+-containing conformation in the absence of Ca2+; and (C) such complexes are highly resistant to cleavage by tPA and, if cleaved by other enzymes, the TSP-1 fragments remain bound to other ECM components. These characteristics have profound significance for platelet adhesion and cell migration into wounds where Ca2+ concentrations are reduced. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222132     DOI: 10.1006/excr.1999.4415

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  6 in total

Review 1.  Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

Authors:  G E Davis; K J Bayless; M J Davis; G A Meininger
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria.

Authors:  Ulrike Binsker; Thomas P Kohler; Sven Hammerschmidt
Journal:  J Innate Immun       Date:  2019-02-27       Impact factor: 7.349

3.  Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.

Authors:  Barbara Margosio; Marco Rusnati; Katiuscia Bonezzi; Blue-Leaf A Cordes; Douglas S Annis; Chiara Urbinati; Raffaella Giavazzi; Marco Presta; Domenico Ribatti; Deane F Mosher; Giulia Taraboletti
Journal:  Int J Biochem Cell Biol       Date:  2007-10-09       Impact factor: 5.085

4.  Calcium indirectly regulates immunochemical reactivity and functional activities of the N-domain of thrombospondin-1.

Authors:  Maria J Calzada; Svetlana A Kuznetsova; John M Sipes; Rui G Rodrigues; Jo Anne Cashel; Douglas S Annis; Deane F Mosher; David D Roberts
Journal:  Matrix Biol       Date:  2007-12-15       Impact factor: 11.583

5.  Plasma degradome affected by variable storage of human blood.

Authors:  Leon F A van Dullemen; Marie-Laëtitia Thézénas; Rutger J Ploeg; Benedikt M Kessler; Maria Kaisar; M Zeeshan Akhtar; Honglei Huang; Sandrine Rendel; Philip D Charles; Roman Fischer
Journal:  Clin Proteomics       Date:  2016-09-26       Impact factor: 3.988

6.  The interaction of Thrombospondins with extracellular matrix proteins.

Authors:  Kemin Tan; Jack Lawler
Journal:  J Cell Commun Signal       Date:  2009-10-16       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.